EMFAT
PTLA

Emerald Mutual Fund Advisers Trust’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-188,640
Closed -$4.51M 336
2019
Q4
$4.51M Sell
188,640
-280,344
-60% -$6.7M 0.18% 141
2019
Q3
$12.6M Sell
468,984
-6,950
-1% -$186K 0.56% 61
2019
Q2
$12.9M Buy
475,934
+102,155
+27% +$2.77M 0.51% 74
2019
Q1
$13M Buy
+373,779
New +$13M 0.52% 63
2018
Q1
Sell
-443,328
Closed -$21.6M 272
2017
Q4
$21.6M Buy
443,328
+68,420
+18% +$3.33M 0.86% 32
2017
Q3
$20.3M Buy
374,908
+12,197
+3% +$659K 0.84% 33
2017
Q2
$20.4M Buy
362,711
+147,270
+68% +$8.27M 0.89% 37
2017
Q1
$8.44M Sell
215,441
-171,252
-44% -$6.71M 0.39% 93
2016
Q4
$8.68M Sell
386,693
-348,842
-47% -$7.83M 0.41% 87
2016
Q3
$16.7M Buy
735,535
+99,009
+16% +$2.25M 0.85% 37
2016
Q2
$15M Buy
636,526
+199,162
+46% +$4.7M 0.84% 38
2016
Q1
$8.92M Buy
437,364
+234,370
+115% +$4.78M 0.5% 79
2015
Q4
$10.4M Buy
202,994
+10,730
+6% +$552K 0.55% 76
2015
Q3
$8.19M Sell
192,264
-122,425
-39% -$5.22M 0.54% 67
2015
Q2
$14.3M Sell
314,689
-42,294
-12% -$1.93M 1.11% 24
2015
Q1
$12.9M Buy
356,983
+19,800
+6% +$717K 1.06% 26
2014
Q4
$9.55M Buy
337,183
+52,972
+19% +$1.5M 0.83% 46
2014
Q3
$7.19M Buy
284,211
+83,190
+41% +$2.1M 0.69% 56
2014
Q2
$5.87M Buy
201,021
+3,471
+2% +$101K 0.54% 73
2014
Q1
$5.12M Sell
197,550
-123,010
-38% -$3.19M 0.49% 81
2013
Q4
$8.48M Buy
320,560
+174,610
+120% +$4.62M 0.51% 77
2013
Q3
$3.9M Buy
145,950
+6,601
+5% +$177K 0.54% 70
2013
Q2
$3.42M Buy
+139,349
New +$3.42M 0.58% 68